Dataset Information


Decorin mimic inhibits vascular smooth muscle proliferation and migration.

ABSTRACT: Over the past 10 years, the number of percutaneous coronary intervention procedures performed in the United States increased by 33%; however, restenosis, which inhibits complete functional recovery of the vessel wall, complicates this procedure. A wide range of anti-restenotic therapeutics have been developed, although many elicit non-specific effects that compromise vessel healing. Drawing inspiration from biologically-relevant molecules, our lab developed a mimic of the natural proteoglycan decorin, termed DS-SILY, which can mask exposed collagen and thereby effectively decrease platelet activation, thus contributing to suppression of vascular intimal hyperplasia. Here, we characterize the effects of DS-SILY on both proliferative and quiescent human SMCs to evaluate the potential impact of DS-SILY-SMC interaction on restenosis, and further characterize in vivo platelet interactions. DS-SILY decreased proliferative SMC proliferation and pro-inflammatory cytokine secretion in vitro in a concentration dependent manner as compared to untreated controls. The addition of DS-SILY to in vitro SMC cultures decreased SMC migration and protein synthesis by 95% and 37%, respectively. Furthermore, DS-SILY decreased platelet activation, as well as reduced neointimal hyperplasia by 60%, in vivo using Ossabaw swine. These results indicate that DS-SILY demonstrates multiple biological activities that may all synergistically contribute to an improved treatment paradigm for balloon angioplasty.

PROVIDER: S-EPMC3838406 | BioStudies |

REPOSITORIES: biostudies

Similar Datasets

| S-EPMC4052849 | BioStudies
| S-EPMC6368354 | BioStudies
| S-EPMC5292946 | BioStudies
2018-01-01 | S-EPMC6082402 | BioStudies
| S-EPMC4426039 | BioStudies
| S-EPMC3302687 | BioStudies
| S-EPMC6341618 | BioStudies
| S-EPMC3819590 | BioStudies
2017-01-01 | S-EPMC5721816 | BioStudies
| S-EPMC4323184 | BioStudies